The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Schreiber, Hans
One or more keywords matched the following items that are connected to Schreiber, Hans
Item TypeName
Concept T-Lymphocytes, Cytotoxic
Academic Article A tumor escape variant that has lost one major histocompatibility complex class I restriction element induces specific CD8+ T cells to an antigen that no longer serves as a target.
Academic Article DNA sequence analysis of T-cell receptor genes reveals an oligoclonal T-cell response to a tumor with multiple target antigens.
Academic Article Genetically engineered vaccines. Comparison of active versus passive immunotherapy against solid tumors.
Academic Article Immunodominance deters the response to other tumor antigens thereby favoring escape: prevention by vaccination with tumor variants selected with cloned cytolytic T cells in vitro.
Academic Article Tumor cells induce cytolytic T cells to a single immunodominant mutant peptide.
Academic Article Tracking the common ancestry of antigenically distinct cancer variants.
Academic Article Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptide.
Academic Article Role of TGF-beta in immune-evasion of cancer.
Academic Article MHC class I restricted T cells and immune surveillance against transplanted ultraviolet light-induced tumors.
Academic Article C-kit+ FcR+ myelocytes are increased in cancer and prevent the proliferation of fully cytolytic T cells in the presence of immune serum.
Academic Article Mechanism of tumor rejection in anti-CD3 monoclonal antibody-treated mice.
Academic Article Induced sensitization of tumor stroma leads to eradication of established cancer by T cells.
Academic Article Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes.
Academic Article Rapid destruction of the tumor microenvironment by CTLs recognizing cancer-specific antigens cross-presented by stromal cells.
Academic Article Recurrence of intracranial tumors following adoptive T cell therapy can be prevented by direct and indirect killing aided by high levels of tumor antigen cross-presented on stromal cells.
Academic Article CD40 ligation restores cytolytic T lymphocyte response and eliminates fibrosarcoma in the peritoneum of mice lacking CD4+ T cells.
Academic Article Spleen cells from young but not old immunized mice eradicate large established cancers.
Academic Article Synergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.
Academic Article Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.
Academic Article CD4+ and B lymphocytes in transplantation immunity. II. Augmented rejection of tumor allografts by mice lacking B cells.
Academic Article Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
Academic Article Bystander elimination of antigen loss variants in established tumors.
Academic Article Tumors with reduced expression of a cytotoxic T lymphocyte recognized antigen lack immunogenicity but retain sensitivity to lysis by cytotoxic T lymphocytes.
Search Criteria
  • T Lymphocytes Cytotoxic